Edition:
United Kingdom

Profile: Astellas Pharma Inc (4503.T)

4503.T on Tokyo Stock Exchange

1,510JPY
20 May 2019
Change (% chg)

-- (--)
Prev Close
¥1,510
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
6,168,356
52-wk High
¥2,056
52-wk Low
¥1,356

Astellas Pharma Inc. is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company is involved in the manufacture and sale of pharmaceutical products in Japan, the United States, Europe, China, Korea, Taiwan and other markets through its subsidiaries. Its main products include immunosuppressive drug Prograf, overactive bladder agent Vesicare, Protopic ointment for atopic dermatitis, Harnal for prostatic and urethral smooth muscle, and antimycotic agent Funguard, among others. It also provides pharmaceutical products for gastritis, osteoporosis, hypertension, schizophrenia, rheumatoid arthritis, atopic dermatitis and other diseases. The Company also engages in the research and development of ophthalmology pharmaceuticals through its subsidiaries.

Company Address

Astellas Pharma Inc

2-5-1, Nihombashihon-cho
CHUO-KU   TKY   103-8411
P: +813.32443000

Company Web Links